Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. 02190
02190 logo

02190 Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
24.080
Open
23.980
VWAP
23.63
Vol
398.38K
Mkt Cap
--
Low
23.420
Amount
9.42M
EV/EBITDA(TTM)
27.86
Total Shares
--
EV
779.09M
EV/OCF(TTM)
--
P/S(TTM)
6.53

Events Timeline

No data

No data

News

PRnewswire
8.5
01-16PRnewswire
Zylox-Tonbridge Acquires Optimed to Accelerate Global Expansion
  • Global Expansion Milestone: Zylox-Tonbridge has entered into an acquisition agreement with Germany's Optimed, aiming to accelerate the global adoption of innovative vascular solutions by integrating R&D, manufacturing, and commercialization platforms, which is expected to significantly enhance market penetration.
  • Operational Synergies: The acquisition will integrate the sales networks of both companies, leveraging Optimed's long-standing customer relationships in over 70 countries to improve product time-to-market and strengthen competitiveness in the European market.
  • Efficient R&D Capabilities: Zylox-Tonbridge will fully unlock its R&D and manufacturing synergies in China and Germany, ensuring the provision of high-quality, reliable innovative medical solutions to meet evolving customer needs in global markets.
  • Leadership Integration: Following the acquisition, Optimed's CEO Rüdiger Hausherr will continue to lead Optimed and report to Zylox-Tonbridge's Chairman Jonathon Zhong Zhao, ensuring strategic alignment and collaborative growth between the two companies.
PRnewswire
8.5
01-16PRnewswire
Zylox-Tonbridge Acquires Optimed to Accelerate Global Expansion
  • Global Expansion Milestone: Zylox-Tonbridge's acquisition of Germany-based Optimed marks a significant milestone in its global expansion strategy, expected to enhance market entry efficiency by integrating R&D, manufacturing, and commercialization platforms.
  • Operational Synergies: The acquisition is set to generate operational synergies by expanding the manufacturing base in Germany, ensuring a reliable supply of high-quality medical solutions while integrating both companies' sales networks to improve operational efficiency and reduce costs.
  • Complementary Product Portfolios: Optimed's established sales network across over 70 countries and long-standing relationships with clinical experts will enable Zylox-Tonbridge to bring innovative products to market more rapidly, enhancing its competitiveness in the global market.
  • Leadership Integration: Following the acquisition, Optimed's CEO Rüdiger Hausherr will continue to lead and report to Zylox-Tonbridge's CEO Jonathon Zhong Zhao, ensuring strategic alignment and collaborative development between the two companies.
PRnewswire
8.5
01-12PRnewswire
Zylox-Tonbridge Hosts Investor Open Day, Showcasing Global Competitiveness
  • Investor Open Day: Zylox-Tonbridge hosted its Investor Open Day at the Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts, showcasing its global competitiveness and innovation strategy aimed at enhancing market position through R&D-driven innovation and a global manufacturing platform.
  • Product Innovation Showcase: The company highlighted its image-guided endovascular therapy platform, including the world's only real-time visualization-guided plaque removal solution, the ZYLOX Pantheris™, marking a significant advancement in precision intervention and elevating global medical standards.
  • Accelerated Global Expansion: By the end of 2025, Zylox-Tonbridge established commercial coverage in 83 countries and regions and formed strategic partnerships with over 80 distributors and commercial partners, demonstrating the success of its globalization strategy and market penetration capabilities.
  • Sustainable Growth Strategy: The CEO stated that by integrating innovation, industrialized manufacturing, and global commercialization, Zylox-Tonbridge is building a globally competitive vascular intervention platform, with cumulative product use expected to exceed one million procedures by 2025, reflecting strong physician adoption of its technologies.
Wall Street analysts forecast 02190 stock price to rise
0 Analyst Rating
Wall Street analysts forecast 02190 stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for (02190.HK) is 28.97, compared to its 5-year average forward P/E of 78.67. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
78.67
Current PE
28.97
Overvalued PE
394.84
Undervalued PE
-237.51

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.75
Current EV/EBITDA
21.43
Overvalued EV/EBITDA
32.47
Undervalued EV/EBITDA
-33.96

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
9.94
Current PS
6.01
Overvalued PS
22.15
Undervalued PS
-2.27

Financials

AI Analysis
Annual
Quarterly

Whales Holding 02190

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (02190) stock price today?

The current price of 02190 is 23.7 USD — it has decreased -1.74

What is (02190)'s business?

What is the price predicton of 02190 Stock?

Wall Street analysts forecast 02190 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02190 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (02190)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (02190)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (02190). have?

(02190) has 0 emplpoyees as of April 03 2026.

What is (02190) market cap?

Today 02190 has the market capitalization of 0.00 USD.